Diabetes

Article	Citations
352-OR: Regulation of Melanocortin Receptor 4 (MC4R) Ciliary Trafficking	175
983-P: Long-Term Improvement in CGM-Measured Glycemic Control in Adults with Type 2 Diabetes Not Treated with Insulin—Real-World Data	96
1082-P: Online Clinician Education Results in Performance Changes in Clinical Practice Related to Obesity Management in Patients With and Without Type 2 Diabetes	91
1465-P: Identification of GCK Gene Variants and Clinical Characterization in Japanese Pediatric MODY2 Cases	81
661-P: Use of a Sequential Continuous Glucose Monitoring with or without Exercise Tracker on Glycaemic Control in Middle-Aged Patients with Diabetes Mellitus	78
2054-LB: Mitigating Adipose Tissue Dysfunction and Insulin Resistance in Obesity via SVEP1 Peptide-Mediated Suppression of Adipose Tissue Macrophage-Induced Inflammation	74
1081-P: Trends in Treatment Goal Attainment of Cardiovascular Risk Factors in Chilean Adults with Diabetes Mellitus—Results from the National Health Survey 2016–2017	73
141-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a U.S. Payer Perspective in Patients with Type 2 Di	72
1682-P: Factors Associated with Postprandial Suppression of Endogenous Glucose Production in People without Diabetes	67
1708-P: Development of a Needle-Free, Self-Applied Microarray Patch for GLP-1 Delivery	66
880-P: Effects of Energy Dosing on Safety and Efficacy in an Open-Label Study of Endoscopic Pulsed Electric Field Induced Electroporation in Type 2 Diabetes (REGENT-1 Trial)	66
71-OR: ADA Presidents' Select Abstract: HLA-Focused Meta-Genetic Risk Score (GRS) Performance in Populations of Diverse Ancestry with Type 1 Diabetes	66
574-P: Meta-analysis Shows Mind- and Body-Based Interventions Improve Glycemic Control in Patients with Type 2 Diabetes	62
249-OR: Cystatin C Predicts Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with and among Those without Type 2 Diabetes	59
1478-P: Polygenic Risk Score Predicts Incident Cardiovascular Disease in People with Diabetes at Borderline or Intermediate 10-Year ASCVD Risk	58
2037-LB: Considerations for Calculating and Reporting CGM Wear-Time in Research Settings	56
1638-P: Oxidized Lipids Cause Ceramide Accumulation and Insulin Resistance in Skeletal Muscle	48
468-P: Association between Sudomotor Function and Coronary Atherosclerosis in Patients with Type 2 Diabetes	48
261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education	47
1034-P: No “Honeymoon” for Youth, in Particular Blacks, Diagnosed with Diabetes during the First Year of the COVID-Pandemic	46
1740-P: Regulation of Endocrine Cell Alternative Splicing Revealed by Single-Cell RNA Sequencing in Type 2 Diabetes	45
1078-P: Elderly Patient with DM2 during the COVID-Pandemia: Forgotten but Good Glycemic Control	44
921-P: Impact of Heart Rate and Step Count on Deep Learning Glucose Prediction Models during Physical Activity	44
1451-P: Peri-Islet Fibrosis in Cystic Fibrosis Is Associated with Altered Alpha-Cell Phenotype	40
697-P: Evaluation of Acceptance and Commitment Therapy on Glycemic Control in Type 2 Diabetes Patients	40

68-OR: Influence of the Type 1 Diabetes Genetic Risk Score on Response to Immunotherapies for Type 1 Diabetes Prevention	39
1558-P: Immunological Role of Hybrid Insulin Peptide in Type 1 Diabetes in Asia	38
727-P: A New HbA1c Test Based on a Cellular Stiffness Measurement of Red Blood Cells	38
171-LB: Estimating the Immunological Risk for Type 1 Diabetes from a CGM-Based One Week Self-Administered Home Test	38
1591-P: Effects of Light Exposure during Sleep on Glycemic Control in Type 1 Diabetes	38
240-OR: Quantifying Glucose Utilization and Endogenous Glucose Production during Resistance Exercise in People with Type 1 Diabetes (T1D)	37
1586-P: Association between PCSK7 Levels and NAFLD Severity in KADEM Study	37
478-P: Application of Plasma Proteomics to Explore Potential Biomarkers of Diabetic Macular Edema	34
562-P: A Social Media Intervention Shows Promise to Improve Health Outcomes in Low-Income Immigrants with Type 2 Diabetes—Evidence from a Pilot RCT	34
252-OR: Maternal Obesity and Diabetes during Pregnancy and Quantitative Checklist for Autism in Toddlers (QCHAT) Scores in Offspring	34
633-P: Insight to the Association between Serum Fibroblast Growth Factor 23 Levels and Presarcopenia in Nondiabetic Individuals—A Longitudinal Cohort Study	34
280-OR: Insulin Sensitivity following an In-Home Sleep and Circadian Intervention for Habitually Short-Sleeping Adolescents	34
718-P: A High FODMAP Diet Reduces Glycemic Excursion without Increasing Gastrointestinal Symptoms in Individuals with Prediabetes Treated with Metformin—A Randomized Crossover Controlled-Feeding Trial	33
1641-P: Effect of Specific Weight-Reducing Interventions on Metabolic and Immunological Outcomes in Mice	33
179-OR: Improved A1C and TIR with Once-Weekly Insulin Icodec vs. Insulin Glargine U100 in Insulin-Naïve T2D—ONWARDS 1	33
99-OR: AgRP Neuron Hyperactivity Drives Hyperglycemia in a Mouse Model of Type 2 Diabetes	32
366-P: Machine Learning Reveals CGM Superiority over Hypoglycemia Awareness Questionnaires in Discriminating Individuals with Severe Hypoglycemia	32
1358-P: Diabetes Prediction without Blood Tests—The Role of Retinal Imaging and Artificial Intelligence	32
1478-P: Incidence and Glucose Trends among Patients with Acute Stroke and Stress Hyperglycemia—Insights from a Descriptive Analysis	32
58-LB: Antidiabetic Effects of Pediococcus acidilactici pA1c on HFD-Induced Mice	31
609-P: Virtual Peer Groups (VPG) for Adolescents and Young Adults (AYA) with Type 1 Diabetes (T1D) : Patient-Reported Importance of Specific Features	30
643-P: Exploring Eating Styles of Older Adults with Type 1 Diabetes (T1D)	30
967-P: The Use of Hybrid Closed-Loop Insulin Delivery in Adolescents and Young Adults with High-Risk Acute Lymphoblastic Leukemia during Induction Chemotherapy	30
30-OR: Effects of Vitamin D Supplementation by Race and Weight Status on Serum Vitamin D Measures and Diabetes Risk in the D2d Study	30
121-OR: Safety, Tolerability, and Metabolic Effects of Once-Weekly GL0034 (Utreglutide) in Individuals with Obesity—A Multiple Ascending Dose Study	29
1823-LB: DiaLOG—A Personalized and Interactive Diabetes Education Platform Empowered with Risk Assessment AI Algorithms and ChatGPT	29
1667-P: Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Patients with Type 2 Diabetes (T2D)	29
500-P: Causal Effect of SGLT2 Inhibition on Diabetes-Related Retinopathy (DR) and Macular Edema (DME)	29
255-LB: Defining Functional Phenotype in Human Islets across Endocrine Cell Composition, Donor Age, Sex, and Ancestry	28
1127-P: Diabetes Risk in Marginalized Urban Settings in Mexico City	28
649-P: Preliminary Outcomes of a Transition Intervention with Adolescents and Young Adults (AYAs) with Type 1 Diabetes (T1D)	28
527-P: Needs of mHealth Diabetes Services from Patients with Poorly Controlled Type 2 Diabetes Mellitus: A Qualitative Study	28
1635-P: Sex Differences in Skeletal Muscle Mitochondrial Function in Rats Fed a High-Fat/High-Sucrose Diet	27
261-LB: Hepatocyte Gdf15 Protects against CCL4-Induced Liver Injury Independent of Changes in Feeding and Inflammation	27
102-OR: Association of Elevated Arterial Stiffness with Cardiac Target Organ Damage in Young Adults with Diabetes: The Search for Diabetes in Youth Study	27
111-OR: Vascular Endothelium-Specific ROCK2 Deficiency Inhibits the Progression of Obesity via Adipocyte Browning	27
248-OR: Diabetes Remission after Gastric Bypass Is Characterized by Upregulation of LXR and Antioxidant-Related Pathways in Jejunum	26
264-OR: Incorporating Shared Decision-Making to Facilitate Equitable Insulin Pump Use among Pediatric Patients with Type 1 Diabetes	26
603-P: Diabetes Distress Is Associated with Poor Glycemic Control after Islet Autotransplantation	26
1268-P: P-tau217 and Cognitive Function in Long-Duration Type 1 Diabetes	26
105-OR: Single-Cell Multiomic Analysis of the Effect of GIP and GIP-1 Mono- and Multi-agonism on the Hypothalamus and Hindbrain	26
1720-P: Epigenetic Regulator Slug Directly Promotes Beige Adipogenesis	26
431-P: Effects of CB1 Antagonist INV-202 in Patients with Metabolic Syndrome—A Randomized, Placebo-Controlled, Double-Blind Phase 1B Study	26
1190-P: Oral Health Status among U.S. Adults with and without Diabetes, 2020	25
531-P: Continuous Glucose Monitoring Placement during Physical Activity	25
1117-P: Comparison between Glucose Management Indicator (GMI) with HbA1c among Patients in a Hybrid Therapeutics Care Model	25
1278-P: Changes in Cardiovascular Disease (CVD) Incidence Due to Remission of Diabetes and Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)	25
475-P: Intermittent Hypoxia Increased the Expression of Intercellular Adhesion Molecule-1 and Endothelial Cell–Specific Molecule-1 in Vascular Endothelial Cells via the Downregulation of MicroRNA-181a	25
1811-PUB: Real-World Safety of the Combined Use of Dapagliflozin and Metformin in Type 2 Diabetes Mellitus Patients in China—Post Hoc Analysis of the DONATE Study	24
1616-P: MENTSH—A Mitochondrial Microprotein and SNP-Associated with Diabetes in People with Native American Ancestry	24

55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects	24
1687-P: Similarities and Differences between Metabolically Unhealthy Lean and Metabolically Unhealthy Obese Individuals	24
213-LB: Combined Oral Contraceptives Drive Inactivity and Hepatic Mitochondrial Oxidative Stress in Female Mice	24
160-LB: Age-Related Adipose Tissue Fibrosis and Neuropathy in the Genetically Diverse HET3 Mouse	23
11-PUB: Transitioning from Dulaglutide to Tirzepatide Improves Glycemic Control in Patients Undergoing Hemodialysis with Type 2 Diabetes—An Assessment by Continuous Glucose Monitoring	23
1416-P: Differences in Treatment and Metabolic Outcome between Males and Females Living with T2D—Results from the Multicenter DPV Registry	23
1387-P: Impacts of Androgen-Deprivation Therapy on Glucose Metabolism	23
1117-P: Variability in Glycemia Measured by CGM in Children and Young Adults with Acute Recurrent or Chronic Pancreatitis	23
1463-P: Heterozygous Variant in NFKB1 Presenting with Autoantibody-Negative (AbNeg) Insulin-Dependent Diabetes (IDDM)	23
1574-P: FoxO1 Links Insulin Resistance to Hepatic Inflammation and Catalyzes the Evolution of Benign Steatosis to Nonalcoholic Steatohepatitis	23
74-PUB: Knowledge, Attitude, and Practice of Individuals with Obesity—Insights from a Large Nationwide Survey	23
201-LB: Benefit of Dual Therapy with GLP-1 RA and SGLT2i on Renal Outcomes in Type 2 Diabetes	22
134-OR: NOD1 Deletion in Skeletal Muscle Protects against Palmitate-Induced Insulin Resistance	22
438-P: Very-Low-Dose Metformin Can Safely Improve Glycemic Control in Type 2 Diabetic Patients Receiving Maintenance Hemodialysis (HD)	22
1792-LB: Long-Term Impact of Glucose Status on Risk of Restenosis after Percutaneous Transluminal Coronary Angioplasty—A Six-Year Follow-up Study	22
410-P: Development and Validation of a Risk Score for Predicting the Initiation of Dialysis in People with and without Diabetes Mellitus	22
665-P: Association between Housing Insecurity and Hemoglobin A1c among Adults with Type 2 Diabetes—A Cross-Sectional Analysis of the All of Us Research Program	22
1410-P: Impacts of COVID-19 on Underserved Communities with Diabetes	22
217-LB: Heterogeneity of Single Cells Obtained from Peripheral Blood Mononuclear Cells Collected from Youth with Recent-Onset Type 1 Diabetes	22
546-P: Comparing Diabetes Risk Perception between Latina and White Women with T2D Risk Factors	22
1101-P: Patient-Centered Weight Management Clinical Decision Support—A Proof-of-Concept Study	22
389-P: A Six-Month Periodic Fasting Reduces Microalbuminuria and Improves Metabolic Control in Patients with Type 2 Diabetes and Diabetic Nephropathy: A Randomized Controlled Study	22
1499-P: Diabetes Technology Use and Acute Complications in Type 1 Diabetes—Racial Disparities Still Persist	22
1692-P: Metabolic Assessment of Semaglutide (a GLP-1R Agonist) and Tirzepatide (a GLP-1R/GIPR Coagonist) in Diet-Induced Obese (DIO) Mice	21
721-P: Mechanisms of Relapse after Lifestyle Intervention–Induced Remission of Prediabetes	21
75-PUB: The Sartorius Fat Fraction Is Independently Associated with Myocardial Fibrosis in Chinese Patients with Obesity	21
1821-PUB: Relationship between Time in Range and Glucose Management Indicator in Adolescents and Children with Type 1 Diabetes Mellitus	21
1044-P: Advancing Quality Improvement Culture among 27 Pediatric and Adult Diabetes Centers	21
750-P: Association of Glucagon-Like Peptide 1 Receptor Agonists with Incident Parkinson’s Disease in U.S. Older Adults with Type 2 Diabetes	21
437-P: Coronary Calcium Score and Cardiovascular Events in Ketosis-Prone Diabetes Compared with T2DM	21
1899-LB: The Predictors and Management of Eating Disorders in Adult Patients with Type 1 Diabetes Mellitus	20
658-P: Evaluating Financial Incentives as a Tool to Increase Medication Adherence—A Systematic Review and Meta-analysis	20
1893-LB: Effects of High Fibers and Probiotics Supplements Diet and Lifestyle Intervention in Type 2 Diabetes or Prediabetes—A Randomized, Double-Blind, Placebo-Controlled Pilot Trial	20
1797-LB: Detection of Potential Therapeutic Target Associated with Coronary Artery Disease in Type 2 Diabetes Patients—System Biology Approach	20
1767-P: Body Composition and Body Mass Index among People with and without Diabetes—A National Analysis, 2011–2018	20
18-OR: Discontinuation of Renin Angiotensin System Inhibitor and Cardiovascular-Renal Events in Advanced Diabetic Kidney Disease	19
1804-LB: Serum Spexin Level Is Negatively Associated with Peripheral Neuropathy and Sensory Pain in Type 2 Diabetes	19
1041-P: Assessing the Value of Managing Diabetic Kidney Disease from a U.S. Health Care Perspective	19
19-OR: Monitoring Stage 2 to Stage 3 Transition in Type 1 Diabetes Using Continuous Glucose Monitoring (CGM)	19
600-P: The Healthy Gut Diet for Preventing Gestational Diabetes Improves Dietary Intake and Diet Quality	19
978-P: Correlation between Continuous Glucose Monitoring Metrics, Oral Glucose Tolerance Test, and HbA1c in Individuals with Impaired Glucose Tolerance	19
1998-LB: Previously Frozen Beta-Cell Transcriptional Response to Cytokine Treatment Mirrors That of Fresh Beta Cells	19
1435-P: Improvements in Metabolic Health from Spanish-Delivered Care Are Similar to English-Delivered Care in a Carbohydrate-Restricted Nutrition Therapy Program	18
842-P: Improvement in Time in Range after Smart Insulin Pen Initiation in Austria	18
1777-P: Three-Dimensional Imaging Reveals Pancreatic Islet Fast Calcium Wave Origin Formation	18
783-P: Elucidating the Benefit of Pump-Delivered Subcutaneous GLP-1R Agonist—Exploratory Study in the DIO Mouse	18
507-P: Trajectories of Inflammatory Proteins over Diabetic Wound Healing Course	18
946-P: Multicenter Quality Improvement Project: Increasing Depression Screening across Six Pediatric Endocrinology Centers in the U.S.	18
1928-LB: Understanding the Burden of Digital Care—Field Testing the TBQ+D in Patients Living with Diabetes	18
252-OR: Associations of Serum Lipid Profiles with Diabetic Macular Edema and Retinal Structural Alterations	18
495-P: Fully Immersive Virtual Reality Improves Empathy towards People with Diabetes	18
422-P: Type 2 Diabetes and the Individual Perception of Risk for Cardiovascular Death in Coronary Artery Disease Patients	18
391-P: Targeted Deletion of Rho-Associated Coiled-Coil–Containing Protein Kinase 2 in Kidney Tubules Suppresses Expression and Function of Mineralocorticoid Receptor in Mice	18
2101-LB: Recruitment Strategies to Increase the Reach of the National Diabetes Prevention Program in Rural Populations	17
Comment on Carrasco et al. Spatial Environment Affects HNF4A Mutation-Specific Proteome Signatures and Cellular Morphology in hiPSC-Derived β-Like Cells. Diabetes 2022;71:862–869	17
46-OR: Amelioration of Insulin Resistance after Delivery Lowers the Risk of Postpartum Type 2 Diabetes in Women with Gestational Diabetes Mellitus	17
1066-P: Sleep Habits and Their Impact on CGM Parameters in Patients with Type 1 Diabetes	17
594-P: Exercise Timing Has Limited Effect on Glycemic Profile in a Cluster of Well-Controlled Youth with Type 1 Diabetes	17
Comparison of β-Cell Function and Insulin Sensitivity Between Normal-Weight and Obese Chinese With Young-Onset Type 2 Diabetes	17
827-P: Patient-Reported Outcomes with Use of Inhaled Technosphere Insulin (TI)	17
Unveiling Novel Markers and Modeling Clinical Prediction of Treatment Effects Are Equally Important for Implementing Precision Therapeutics	17
1492-P: IL-8/CXCL8 May Identify a New Type 1 Diabetes Endotype	17
1764-P: Assessing Gene Expression Profile and Insulin Secretion in Human Beta Cells (EndoC-BH3) under Glucose Exposure	17
63-PUB: Diabetes Control and Complications in South India—Three-Year Results of LANDMARC Trial	17
Expression of Concern. Shuangxi Wang, Jian Xu, Ping Song, Benoit Viollet, and Ming-Hui Zou. In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydr	17
1801-LB: Discovering Novel Cathepsin L Inhibitors Using Artificial Intelligence for Diabetic Nephropathy	17
1148-P: Risk Factor Control and Risk of Hospitalization for Heart Failure in Diabetic Patients	17
Loss of Glomerular Permselectivity in Type 2 Diabetes Associates With Progression to Kidney Failure	17
1301-P: The Effect of Insulin on α-Aminoadipic Acid Metabolism in Polycystic Ovary Syndrome (PCOS) Patients with Insulin Resistance	16
612-P: The Effectiveness of Lifestyle, Metformin, or Dietary Supplements for the Prevention of Gestational Diabetes Mellitus (GDM) by Participant Characteristics—A Systematic Review and Meta-analysis	16
1422-P: Understanding COVID-19 Impacts among Underserved Adults with Diabetes Using the Social-Ecological Model	16
1629-P: Association between Dyslipidemia and Myosteatosis Evaluated by Abdominal Computed Tomography	16
1452-P: Financial Toxicity and Cost-Related Nonadherence (CRN) in Adults with Type 1 Diabetes (T1D)—Prevalence and Associations with Social Determinants of Health	16
1844-LB: Community Engaged Research—Lessons Learned from a Pediatric Type 1 Diabetes Study	16
385-P: MDSC-Mediated Neutrophil Extracellular Traps–Based Targeting of Diabetic Vasculopathy—Dapagliflozin for Vascular Remodeling in Diabetic Nephropathy	16
1588-P: Translatable Modeling of Glucagon Actions in Human iPSC-Derived Hepatocytes Uniquely Predicts Differential Clinical Responses to Glucagon Analog Agonist Molecules	16
932-P: MiniMed 780G System Use in a Real-World United States (U.S.) Population Aged 65 Years and Older with Diabetes	16
571-P: Theory-Based Design of a Nutrition-Focused Approach at CGM Initiation for People with T2D	16
770-P: Efficacy and Safety of Tirzepatide in Participants Who Achieved Fasting Serum Glucose Targets at 52 Weeks in SURPASS-3 and SURPASS-4	16
933-P: Effects of Dapagliflozin and Metformin on Vascular Function in Newly Diagnosed Type 2 Diabetes—A Randomized Controlled Trial (DMVascular Study)	16

258-OR: Sustainability of HbA1c Control of Tirzepatide vs. Insulin Glargine in People with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)	16
1127-P: 4T Study—Early CGM Initiation and Tighter Glucose Targets Improves A1C in Youth with T1D	16
999-P: Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)—A	16
150-LB: Diabetes and School Health (DASH) Program—An Innovative School-Based Health Model to Optimize Care for Youth with Type 1 Diabetes	16
118-OR: Fat Distribution Patterns Predict Type 2 Diabetes Risk and Provide Insights into Prediabetic Metabolism	15
1762-P: Regional Body Fat Distribution Is Associated with Higher Risk for Sleep Deficiency and Sleep Disorders	15
1807-PUB: Monocarbonyl Curcumin Analogs C66 and B2BrBC Improve Redox Status in Streptozotocin-Induced Diabetic Rats	15
1707-P: Real-World 12-Month Weight Loss Outcomes of Tirzepatide—The Mayo Clinic Experience	15
1760-P: Mining Animal Venoms as a Source of Insulinotropic Peptides for Potential Diabetes Therapy	15
1706-P: Software-Aided Self Selection of Weight Loss Diet Plan for Facilitating Diabetes Management in Primary Care	15
727-P: A Phase 3 Evaluation of CAMP-Biased GLP-1 Analog Ecnoglutide vs. Dulaglutide in Adults with Type 2 Diabetes	15
1137-P: Continuous Glucose Monitoring (CGM) Use and Its Impact on Glycemic Control and Acute Complications among Older-Onset Type 1 Diabetes Patients within the Veterans Health Administration (VHA)	15
1526-P: A Clinically Optimized Genetic Prediction Model for Differentiating Type 1 and Type 2 Diabetes	15
17-PUB: Glucagon-Like Peptide 1 Receptor Agonists' Heterogeneous Treatment Effects on Asthma Exacerbations—A Causal Machine-Learning Analysis	15
1126-P: Does the Use of a Case Manager Matter in Diabetes Care?	15
1713-P: Deletion of SGK1 in Smooth Muscle Cells Induces Adipose Tissue Beiging and Differential Secretion of Vasokines	15
1223-P: Frequency and Predictors of Level 2 Time Above Range (TAR) in Older Adults with Type 2 Diabetes on Insulin Therapy—Data from the HYPOAGE Prospective Study	15
1571-P: Plasma FGF5 Concentration Correlates Better with Hepatic Steatosis, Blood Glucose, and Specific Plasma Free Fatty Acids than with Other Tissue Fat Accumulation	15
1604-P: The Severity of Metabolic Dysfunction–Associated Steatohepatitis (MASH) Is Associated with Worse Hepatic Steatosis and Insulin Resistance	15
79-OR: Targeted Erasure of DNA Methylation by TET3 with C/EBPδ Rewires Adipogenic Execution for Energy Metabolism	15
Lrtm1 - A Novel Sensor of Insulin Signaling and Regulator of Metabolism and Activity	15
227-LB: Kynurenine Pathway Is Associated with Preservation of Beta-Cell Function in Autoimmune Diabetes	15
1908-LB: A Machine-Learning Framework to Quantify Postprandial Glucose Responses in Gestational Diabetes	15
1726-P: Comparison of Subcutaneous, Visceral, Liver, and Muscle Fat Depots in Relation to Diabetes Risk—A Prospective Cohort Study	15
607-P: Associations of Gut Microbiome with Glycemic Control in a Carbohydrate-Restricted, High-Protein Diet for Type 2 Diabetes Mellitus	15
632-P: Beta-Cell Function Is a Stronger Predictor Than Insulin Resistance for Development of Type 2 Diabetes in Obese Indian Population—A Matched-Pair Cohort Analysis	15
2188-LB: Associations between Alzheimer's Disease (AD) and Obesity—Clinical Trials of NA-813 for AD and NA-931 for Obesity	15
32-PUB: Glycemic Variability after Initiation of SGLT2 Inhibitors in CKD	14
1635-P: Short-Term Production of Circulating Triglycerides Is Positively Associated with Triglyceride Concentration in Adolescents with and without MASLD	14
726-P: Medication Adherence among American Indians with Type 2 Diabetes—Assessing the Quality of Electronic Health Record Data within a Large Tribal Health Care System	14
1397-P: A Cocoa Butter–Based Ketogenic Diet Fails to Improve Glucose Homeostasis and Promote Weight Loss in Obese Mice	14
1022-P: Youth from High-Poverty Neighborhoods Demonstrate Higher HbA1c within Year after Diagnosis of T1D	14
283-OR: Adipose Stromal Cells Increase Insulin Sensitivity and Decrease Liver Gluconeogenesis in a Type 1 DM Mouse Model	14
611-P: Do Social Needs Impact Quality of Life among Adult Medicaid Beneficiaries with Type 2 Diabetes?	14
94-OR: Pathogenic Action of GAD65 Autoantibodies on Islet Function in Type 1 Diabetes	14
1661-P: Exogenous Oxytocin Has No Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals with Obesity	14
429-P: The Difference between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate in Relation to Carotid Plaque Score in Patients with Type 2 Diabetes	14
2176-LB: Circadian Clock Regulation of HIF1a-Dependent Skeletal Muscle Metabolism during Diet-Induced Obesity	14
447-P: C/EBPß-Lin28a Positive Feedback Loop Mediated by C/EBPß Hypomethylation Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells in Restenosis	14
167-LB: Knowledge Retention and Glycemic Control in Participants of Kids in Control of Food (KICk OFF) Program—Virtual vs. On-Site	14
296-OR: Glucagon and Insulin Cross Talk Regulates Hepatic Glycogen Metabolism	14
1040-P: Feasibility and Performance of Continuous Glucose Monitoring (CGM) to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit (CV-ICU)	14
2111-LB: Discrepancies between Creatinine-Cystatin C-Based and Creatinine-Based eGFR and Their Association with Vascular Complications in Adults With Diabetes—The China Diachronic Study	14
2060-LB: Benchmarking AI in Type 1 Diabetes Management—How Well Do Generative AI Platforms Follow ADA SOC?	14
44-LB: Evaluating the Effectiveness of a Novel Form of Online Cognitive Behavioural Therapy for Patients with Type 2 Diabetes and Comorbid Anxiety or Depression	14
1895-LB: Randomized Controlled Trial in a Real-World Setting Shows a Light Touch “Food Is Medicine” Program Improves Health Behaviors and Self-Reported Health Status in People with Diabetes	14
140-OR: Adoption of State-Level Complete Streets Legislations and U.S. Prevalence of Obesity	14
1126-P: Smart Insulin Pens—A Randomized, Crossover Pilot Trial Assessing Glycemic Control and Diabetes-Related Burdens in Adolescents and Emerging Adults with Diabetes	14
Diabetes Genetic Clusters and Clinical Outcomes in American Indians	13
1-PUB: Impaired Kidney Function in Diabetic Patients—A Warning	13
1946-LB: Patterns of Insulin Discontinuation in Youth with New-Onset Type 2 Diabetes	13
72-OR: A Novel Multiancestry Polygenic Score Improves T1D Risk Prediction in Non-European Populations	13
High-Intensity Interval Training, Caloric Restriction, or Their Combination Have Beneficial Effects on Metabolically Acquired Peripheral Neuropathy	13
204-OR: An Early Immune Signature in Prediabetes Can Predict Progression to Type 2 Diabetes	13
502-P: Increasing Provider Referrals to Diabetes Self-Management Education and Support Services: Recommendations from Virtual Focus Groups with Providers in New York State	13
Upregulation of Acid-Sensing Ion Channel 1a in the Anterior Cingulate Cortex by TNF-α/NF-κB Pathway Contributes to Diabetes-Related Pain	13
Adenylosuccinate Mediates Imeglimin-Induced Proliferative and Antiapoptotic Effects in β-Cells	13
785-P: Preclinical Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) Assessments of Sustained-Released Formulation of Once-Monthly Injectable Semaglutide (PT403)	13
671-P: Development of Novel Infrastructure for Diabetes Distress Screening in the Electronic Health Record	13
337-OR: Tirzepatide Improved Markers of Islet-Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared with Semaglutide in People with Type 2 Diabet	13
Plasma Neuronal Growth Regulator 1 May Link Physical Activity to Reduced Risk of Type 2 Diabetes: A Proteome-Wide Study of ARIC Participants	13
1809-PUB: Painful Diabetic Neuropathy—Patients Treated with High-Frequency (10 kHz) Spinal Cord Stimulation (SCS) Experience Significant Reductions in A1C and Weight	13
10-LB: Activation of Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease	13
A 3-Week Ketogenic Diet Increases Skeletal Muscle Insulin Sensitivity in Individuals With Obesity: A Randomized Controlled Crossover Trial	13
2059-LB: NA-931, a Novel Triple IGF-1/GLP-1/GIP Incretin Receptor Agonist Reduces Body Weight and Improves Metabolic Profile in DIO Mice	13
238-OR: Changes In Renal Function after Islet Transplantation in a Single-Centre Cohort in Canada over 20 Years	13
1736-P: Exploring Intrinsic Features of Human Pancreatic a- and ß-Cell Physiology Using Pseudoislets	13
507-P: Human Liver-Specific Regulation of Lipogenesis by Long Noncoding RNA hLMR1	13
218-OR: Time of Exercise Affects Nocturnal Hypoglycemia after Exercise in Adults with Type 1 Diabetes (T1D)—Results from the T1D Exercise Initiative (T1DEXI) Study	13
Of Mice and Men: Toward a Better Model of Diabetic Cardiomyopathy With Application in Female Animals	13
1051-P: Cost-Effectiveness of Flash CGM Compared with SMBG—A Canadian Private-Payer Perspective	13
Perilipin 1 Antibodies in Patients With Acquired Generalized Lipodystrophy	13
Foxj3 Regulates Thermogenesis of Brown and Beige Fat Via Induction of PGC-1α	12
Deficiency of the Hemoglobin-Haptoglobin Receptor, CD163, Worsens Insulin Sensitivity in Obese Male Mice	12
Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses	12
Combined Weight Loss and Exercise Training Alters Skeletal Muscle Subcellular Lipid Localization and Intermuscular Adipose Tissue Cellular Composition	12
75-LB: CT-388, a Novel Once-Weekly Dual GLP-1 and GIP Receptor Modulator, Is Safe, Well-Tolerated, and Produces More than 8% Weight Loss in Four Weeks in Overweight and Obese Adults	12
Building the Glucagon-Like Peptide-1 Receptor Brick by Brick: Revisiting a 1993 Diabetes Classic by Thorens et al.	12
280-LB: Efficacy of a Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults with Preexisting Medical Conditions	12
Polygenic Risk for Type 2 Diabetes in African Americans	12
Electrophysiological Characterization of Inducible Pluripotent Stem Cell–Derived Human β-Like Cells and an SLC30A8 Disease Model	12
Protective Renalase Deficiency in β-Cells Shapes Immune Metabolism and Function in Autoimmune Diabetes	12
849-P: Antidiabetic Effects of TLC-3595, a Selective ACC2 Inhibitor, in ZDF Rats	12
lncRNA-H19 in Fibroblasts Promotes Wound Healing in Diabetes	12
Comment on Baranova et al. Causal Associations Between Basal Metabolic Rate and COVID-19. Diabetes 2023;72:149–154	11
Issues and Events	11
281-OR: Neonatal Outcomes in Early and Incident Gestational Diabetes Mellitus—Are They Normalized with Treatment from 24–28 Weeks’ Gestation?	11
Insulin Regulation of Lysine and α-Aminoadipic Acid Dynamics and Amino Metabolites in Women With and Without Insulin Resistance	11
Functionally Separate Populations of Ventromedial Hypothalamic Neurons in Obesity and Diabetes: A Report on Research Supported by Pathway to Stop Diabetes	11
Erratum. DNA Methylation–Dependent Restriction of Tyrosine Hydroxylase Contributes to Pancreatic β-Cell Heterogeneity. Diabetes 2023;72:575–589	11
1320-P: Raising Prediabetes Awareness and Reducing Type 2 Diabetes Risk through Virtual Care for Overweight and Obesity	11
34-OR: The Effect of Combined Activin A and Myostatin Blockade on Body Composition—A Phase 1 Trial	11
In This Issue of Diabetes	11
962-P: Interim Real-World Ten-Site Data from the National Danish PRO Diabetes Multisector Study (M-PRODIA) Engaging 460 Persons with Diabetes and 30 Health Care Professionals Shows High Acceptability	11
1984-LB: All-Cause Mortality and GI Adverse Effects in Adults with Type 1 Diabetes (T1D) on GLP-1RA	11